1
|
Fricová L, Kommoss S, Scambia G, Ferron G, Kocián R, Harter P, Anchora LP, Bats AS, Novàk Z, Walter CB, Raspagliesi F, Lambaudie E, Bahrehmand K, Andress J, Klát J, Pasternak J, Matylevich O, Szeterlak N, Minář L, Heitz F, Căpîlna ME, Runnebaum I, Cibula D, Sláma J. Reproductive outcomes after fertility-sparing surgery for cervical cancer - results of the multicenter FERTISS study. Gynecol Oncol 2024; 190:179-185. [PMID: 39197417 DOI: 10.1016/j.ygyno.2024.08.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2024] [Revised: 08/15/2024] [Accepted: 08/20/2024] [Indexed: 09/01/2024]
Abstract
INTRODUCTION Fertility-sparing treatment (FST) for patients with cervical cancer intends to achieve oncologic outcomes comparable to those after radical treatment while maximizing reproductive outcomes, including the ability to conceive and minimizing the risk of prematurity. METHODOLOGY International multicentre retrospective FERTISS study focused on patients treated with FST analysed timing of FST relative to pregnancy, conception attempts and methods, abortion rates, prophylactic procedures reducing the risk of severe prematurity, pregnancy duration, and delivery mode. RESULTS Of the 733 patients treated at 44 centres in 13 countries, 49.7% attempted to conceive during median follow-up of 72 months and 22.6% (166/733) patients achieved a successful pregnancy. Success rate was significantly higher after non-radical surgery (63.2%; 122/193) compared to radical trachelectomy (25.7%; 44/171, p < 0.001). Available perinatological data shows that 89.5% (111/124) of the patients became pregnant naturally. There was no significant difference in the abortion rate in the first pregnancy nor delivery success rates between non-radical and radical procedures patients. Preterm delivery (<38 weeks gestation) occurred more frequently after radical than non-radical procedures (76.5% vs. 57.7%, p = 0.15). Almost all patients (97.3%; 73/75) who underwent regular ultrasound cervicometry in pregnancy with subsequent prophylactic procedures delivered a live fetus, compared to 30.6% (15/49) women without such management, p < 0.001. CONCLUSION Patients who underwent non-radical surgery had significantly higher pregnancy rates. Most pregnancies resulted in a viable fetus, but radical trachelectomy led to a higher rate of preterm births in the severe prematurity range. Half of the patients did not attempt pregnancy after FST.
Collapse
Affiliation(s)
- Lenka Fricová
- Department of Obstetrics, Gynecology and Neonatology First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 128 08, Czech Republic
| | - Stefan Kommoss
- Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany; Gynecology, Diakonie-Klinikum Schwäbisch Hall gGmbH, Schwäbisch Hall 74523, Germany
| | - Giovanni Scambia
- Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Heart Rome, Rome 00168, Italy
| | - Gwenael Ferron
- Claudius Regaud Institute-University Cancer Institute, Toulouse, 31300, France
| | - Roman Kocián
- Department of Obstetrics, Gynecology and Neonatology First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 128 08, Czech Republic.
| | - Philipp Harter
- Department of Gynecology & Gynecologic Oncology, Evangelical Clinic Essen Mitte, Essen 45136, Germany
| | - Luigi Pedone Anchora
- Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Heart Rome, Rome 00168, Italy
| | - Anne-Sophie Bats
- Gynecologic and Breast Oncologic Surgery Department, Georges Pompidou European Hospital, Paris, France; University Paris Cité, Paris, 75015, France
| | - Zoltán Novàk
- Department of Gynecology, Hungarian National Institute of Oncology, Budapest 1122, Hungary; Doctoral School of Clinical Medicine, University of Szeged, Hungary
| | | | | | - Eric Lambaudie
- Department of Surgical Oncology, Institut Paoli-Calmettes, Marseille 13009, France
| | - Kiarash Bahrehmand
- Department of Gynecology, Hungarian National Institute of Oncology, Budapest 1122, Hungary; Doctoral School of Clinical Medicine, University of Szeged, Hungary
| | - Jürgen Andress
- Department of Women's Health, Tuebingen University Hospital, Tuebingen 72076, Germany
| | - Jaroslav Klát
- Department of Obstetrics and Gynecology, Faculty of Medicine and Dentistry, Palacky University, University Hospital Olomouc, Olomouc 779 00, Czech Republic
| | - Jana Pasternak
- Department of Women's Health, Tuebingen University Hospital, Tuebingen 72076, Germany
| | - Olga Matylevich
- Gynecologic Oncology Department, N.N. Alexandrov National Cancer Centre of Belarus, Minsk 223040, Belarus
| | - Nina Szeterlak
- Department of Gynecology, Breast Center, Red Cross Clinic Munich Women's Clinic, Munich 80634, Germany
| | - Luboš Minář
- Department of Gynecology and Obstetrics, University Hospital Brno and Masaryk University, Brno 602 00, Czech Republic
| | - Florian Heitz
- Department of Gynecology & Gynecologic Oncology, Evangelical Clinic Essen Mitte, Essen 45136, Germany
| | - Mihai Emil Căpîlna
- First Obstetrics and Gynecology Clinic, "George Emil Palade" University of Medicine, Pharmacy, Science and Technology Târgu Mureș, Târgu Mureș 540136, Romania
| | - Ingo Runnebaum
- Department of Gynecology and Reproductive Medicine, University Hospital Jena, Jena 07747, Germany
| | - David Cibula
- Department of Obstetrics, Gynecology and Neonatology First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 128 08, Czech Republic
| | - Jiří Sláma
- Department of Obstetrics, Gynecology and Neonatology First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 128 08, Czech Republic
| |
Collapse
|
2
|
Ind T. Radical vaginal trachelectomy. Best Pract Res Clin Obstet Gynaecol 2021; 75:65-71. [PMID: 34099413 DOI: 10.1016/j.bpobgyn.2021.04.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2021] [Accepted: 04/30/2021] [Indexed: 10/21/2022]
Abstract
Radical vaginal trachelectomy (RVT) is the oldest fertility-sparing procedure for stage 1b cervical cancer. For that reason, there are more published data for RVT than for all the other radical trachelectomy approaches. However, there are no randomised controlled studies between RVT and radical hysterectomy proving the comparability of survival and no randomised controlled studies comparing a vaginal approach with open, standard laparoscopy and robotic approaches. This article intends to describe the case selection, the procedure and outcomes for RVT.
Collapse
Affiliation(s)
- Thomas Ind
- Royal Marsden Hospital, London, SW3 6JA, UK; St George's University of London, Cranmer Terrace, Tooting, London SW17 0RE, UK.
| |
Collapse
|
3
|
Management of pregnancy after radical trachelectomy. Gynecol Oncol 2021; 162:220-225. [PMID: 33902946 DOI: 10.1016/j.ygyno.2021.04.023] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2021] [Accepted: 04/20/2021] [Indexed: 11/23/2022]
Abstract
Radical trachelectomy (RT) is a surgery for early-stage cervical cancer treatment that preserves the childbearing ability, and its use has become increasingly common worldwide. Thus, the rate of conception in women who have undergone RT is increasing. However, pregnancy after RT is associated with a higher risk of several obstetric complications such as preterm delivery, preterm premature membrane rupture, and abnormal bleeding from varices at the site of uterovaginal anastomosis. Furthermore, since RT have a residual prophylactic cerclage, it is difficult to manage first- and second-trimester miscarriages. There is little previous data on the management of pregnancy after RT. In this review article, we summarize various management methods and experiences to provide a guide to clinicians for perinatal management after RT.
Collapse
|
4
|
Halaska MJ, Drochytek V, Shmakov RG, Amant F. Fertility sparing treatment in cervical cancer management in pregnancy. Best Pract Res Clin Obstet Gynaecol 2021; 75:101-112. [PMID: 33992541 DOI: 10.1016/j.bpobgyn.2021.03.014] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2021] [Accepted: 03/29/2021] [Indexed: 12/09/2022]
Abstract
The article focuses on fertility-sparing management during pregnancy and obstetrical management after fertility-sparing surgery. Over the years, more women in developed countries tend to delay childbirth to a later age, which leads to cervical cancer more often diagnosed during pregnancy. The advances in our understanding of prognosis and treatment options in these patients have helped us to address avenues and to circumvent standard therapy and fetal demise, respecting maternal and fetal chances. Childbearing trends also lead to an increase in the number of patients considering fertility-sparing management when diagnosed with cervical cancer. Such management represents a challenge for obstetricians as prior cervical surgery is a known risk factor for various adverse events. These include decreased fertility, second trimester miscarriage, preterm labor, or preterm premature rupture of membranes. Watchful follow-up and various prophylactic measures are keys when striving for the best possible outcome.
Collapse
Affiliation(s)
- Michael J Halaska
- Dept. of Obstetrics and Gynaecology, Faculty Hospital Kralovske Vinohrady, 3rd Medical Faculty, Charles University, Prague, Czech Republic
| | - Vit Drochytek
- Dept. of Obstetrics and Gynaecology, Faculty Hospital Kralovske Vinohrady, 3rd Medical Faculty, Charles University, Prague, Czech Republic
| | - Roman G Shmakov
- National Medical Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare of Russian Federation, Moscow, Russia
| | - Frédéric Amant
- Dept. Gynaecology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Dept. Oncology, KU Leuven, Belgium; Dept. Obstetrics and Gynaecology, Amsterdam University Medical Centers, the Netherlands.
| |
Collapse
|
5
|
Segarra-Vidal B, Persson J, Falconer H. Radical trachelectomy. Int J Gynecol Cancer 2021; 31:1068-1074. [PMID: 33707207 DOI: 10.1136/ijgc-2020-001782] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2020] [Revised: 02/18/2021] [Accepted: 02/19/2021] [Indexed: 11/04/2022] Open
Abstract
Radical trachelectomy is the 'cornerstone' of fertility-sparing surgery in patients with early-stage cervical cancer wishing to preserve fertility. Growing evidence has demonstrated the oncologic safety and subsequent favorable pregnancy outcomes in well-selected cases. In the absence of prospective trials, the decision on the appropriate surgical approach (vaginal, open, or minimally invasive surgery) should be based on local resources and surgeons' preferences. Radical trachelectomy has the potential to preserve fertility in a large proportion of women with early-stage cervical cancer. However, prematurity and premature rupture of membranes are common obstetric complications after radical trachelectomy for cervical cancer. A multidisciplinary approach is crucial to optimize the balance between oncologic and obstetric outcomes. The purpose of this review is to provide an updated overview of the technical, oncologic, and obstetric aspects of radical trachelectomy.
Collapse
Affiliation(s)
| | - Jan Persson
- Department of Obstetrics and Gynecology, Lund University Hospital, Lund, Sweden
| | - Henrik Falconer
- Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden
| |
Collapse
|
6
|
Qu J, Li Y, Liao S, Yan J. The Effects of Negative Elements in Environment and Cancer on Female Reproductive System. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2021; 1300:283-313. [PMID: 33523439 DOI: 10.1007/978-981-33-4187-6_13] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
With the development of human society, factors that contribute to the impairment of female fertility is accumulating. Lifestyle-related risk factors, occupational risk factors, and iatrogenic factors, including cancer and anti-cancer treatments, have been recognized with their negative effects on the function of female reproductive system. However, the exact influences and their possible mechanism have not been elucidated yet. It is impossible to accurately estimate the indexes of female fertility, but many researchers have put forward that the general fertility has inclined through the past decades. Thus the demand for fertility preservation has increased more and more dramatically. Here we described some of the factors which may influence female reproductive system and methods for fertility preservation in response to female infertility.
Collapse
Affiliation(s)
- Jiangxue Qu
- Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China
| | - Yuehan Li
- Department of Gynaecology and Obstetrics, Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Shujie Liao
- Department of Gynaecology and Obstetrics, Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
| | - Jie Yan
- Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.
| |
Collapse
|
7
|
Šimják P, Cibula D, Pařízek A, Sláma J. Management of pregnancy after fertility-sparing surgery for cervical cancer. Acta Obstet Gynecol Scand 2020; 99:830-838. [PMID: 32416616 DOI: 10.1111/aogs.13917] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2020] [Revised: 04/17/2020] [Accepted: 05/12/2020] [Indexed: 12/14/2022]
Abstract
Cervical cancer is increasingly diagnosed in women who have not yet completed their reproductive plans. For women with early-stage disease (FIGO stage IA1-IB1), fertility-sparing procedures, such as conization, trachelectomy or radical trachelectomy, represent the treatments of choice. However, women who undergo repeated conization or trachelectomy represent a challenge for obstetricians because they are at increased risk of infertility, mid-trimester miscarriage, preterm premature rupture of membranes and preterm delivery. So far, the evidence-based guidance on the management of these pregnancies is limited. This article reviews the literature discussing pregnancy management in women after fertility-sparing surgery for early cervical cancer. Although the evidence is limited, certain measures are desirable, including screening and treatment of asymptomatic bacteriuria, screening for cervical incompetence and progressive cervical shortening by transvaginal ultrasonography, and fetal fibronectin testing. Vaginal progesterone supplementation should be primary prevention for all women after trachelectomy. Women with a history of preterm delivery or late miscarriage may benefit from cervical cerclage. Elective delivery by cesarean section in the early-term period is desirable.
Collapse
Affiliation(s)
- Patrik Šimják
- Department of Gynecology and Obstetrics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
| | - David Cibula
- Department of Gynecology and Obstetrics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
| | - Antonín Pařízek
- Department of Gynecology and Obstetrics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
| | - Jiří Sláma
- Department of Gynecology and Obstetrics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
| |
Collapse
|
8
|
Nezhat C, Roman RA, Rambhatla A, Nezhat F. Reproductive and oncologic outcomes after fertility-sparing surgery for early stage cervical cancer: a systematic review. Fertil Steril 2020; 113:685-703. [DOI: 10.1016/j.fertnstert.2020.02.003] [Citation(s) in RCA: 31] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2019] [Revised: 01/25/2020] [Accepted: 02/03/2020] [Indexed: 12/21/2022]
|
9
|
Sanchez-Migallon A, Lago V, Matute L, Domingo S. Obstetric complications as a challenge after radical trachelectomy: a review of the literature. J OBSTET GYNAECOL 2019; 39:885-888. [PMID: 31064268 DOI: 10.1080/01443615.2019.1577812] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
Cervical cancer is the fourth most frequent cancer in women worldwide and the ninth cause of death in women between 30 and 49 years of age. Increase in early detection and diagnosis has allowed the implementation of more conservative management strategies. The radical trachelectomy (RT) is considered the treatment of choice for patients with early stage cervical cancer that desire fertility preservation, without compromising oncologic outcomes. The published data regarding reproductive and obstetric outcomes after RT reports decreased fertility, and increased abortion rates, prematurity and obstetric complications. On the other hand, data on oncologic outcomes has not shown higher rates of residual disease compared to radical hysterectomy. Data on obstetric outcomes following RT is scarce, generating controversy. We present the case of a patient diagnosed with stage IB1 cervical cancer managed with a vaginal radical trachelectomy (VRT), who subsequently had two successful gestations that resulted in premature deliveries with associated neonatal morbidity.
Collapse
Affiliation(s)
| | - Victor Lago
- Department of Gynecologic Oncology, University and Polytechnic Hospital La Fe , Valencia , Spain
| | - Luis Matute
- Department of Gynecologic Oncology, University and Polytechnic Hospital La Fe , Valencia , Spain
| | - Santiago Domingo
- Department of Gynecologic Oncology, University and Polytechnic Hospital La Fe , Valencia , Spain
| |
Collapse
|
10
|
Tirlapur A, Willmott F, Lloyd P, Brockbank E, Jeyarajah A, Rao K. The management of pregnancy after trachelectomy for early cervical cancer. ACTA ACUST UNITED AC 2017. [DOI: 10.1111/tog.12415] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Anushka Tirlapur
- Whipps Cross University Hospital, Barts Health NHS Trust; Whipps Cross Road London E11 1NR UK
| | - Fredric Willmott
- Whipps Cross University Hospital, Barts Health NHS Trust; Whipps Cross Road London E11 1NR UK
| | - Philippa Lloyd
- Royal London Hospital, Barts Health NHS Trust; Whitechapel Road London E1 1BB UK
| | - Elly Brockbank
- Royal London Hospital, Barts Health NHS Trust; Whitechapel Road London E1 1BB UK
| | - Arjun Jeyarajah
- Royal London Hospital, Barts Health NHS Trust; Whitechapel Road London E1 1BB UK
| | - Kalpana Rao
- Newham University Hospital, Barts Health NHS Trust; Glen Road London E13 8SL UK
| |
Collapse
|
11
|
Bentivegna E, Maulard A, Pautier P, Chargari C, Gouy S, Morice P. Fertility results and pregnancy outcomes after conservative treatment of cervical cancer: a systematic review of the literature. Fertil Steril 2016; 106:1195-1211.e5. [DOI: 10.1016/j.fertnstert.2016.06.032] [Citation(s) in RCA: 114] [Impact Index Per Article: 14.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2016] [Revised: 06/09/2016] [Accepted: 06/20/2016] [Indexed: 01/17/2023]
|
12
|
Lim YK, Lek SM, Yeo SH. Obstetric care after radical abdominal trachelectomy in a patient with stage IB1 cervical cancer: A case report and a review of medical literature. Gynecol Oncol Rep 2016; 17:86-8. [PMID: 27536720 PMCID: PMC4976664 DOI: 10.1016/j.gore.2016.07.005] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/23/2016] [Revised: 07/27/2016] [Accepted: 07/28/2016] [Indexed: 01/21/2023] Open
Abstract
•A case on obstetric care after radical trachelectomy in early cervical cancer•Fertility sparing surgery provides favorable oncological and obstetrical outcomes.•Multidisciplinary teams are essential in managing this patient population.
Collapse
Affiliation(s)
- Yong Kuei Lim
- KK Women's and Children's Hospital, Department of Gynaecological Oncology, 100 Bukit Timah Road, Singapore 229899, Singapore
| | - Sze Min Lek
- Duke-National University of Singapore Medical School, 8 College Road, Singapore 169857, Singapore
| | - Seow Heong Yeo
- KK Women's and Children's Hospital, Department of Maternal-Foetal Medicine, 100 Bukit Timah Road, Singapore 229899, Singapore
| |
Collapse
|
13
|
Radical Vaginal Trachelectomy with Laparoscopic Pelvic Lymphadenectomy for Fertility Preservation in Young Women with Early-Stage Cervical Cancer. Indian J Surg 2015; 78:265-70. [PMID: 27574342 DOI: 10.1007/s12262-015-1351-3] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2015] [Accepted: 09/14/2015] [Indexed: 10/23/2022] Open
Abstract
The primary objective of this study was to describe our experience with the conservative treatment of early-stage cervical cancer (stages IA1, IA2, and IB1) with radical vaginal trachelectomy (RVT) and laparoscopic pelvic lymphadenectomy. This retrospective observational case series included 36 patients with early cervical cancer. Radical trachelectomy and laparoscopic pelvic lymphadenectomy were performed as described by D. Dargent in 32 of these cases. Oncologic, reproductive, and obstetric outcomes were observed subsequently over a median period of 42 (24-96) weeks. A total of 32 RVTs were preformed with a mean operating time of 117 ± 22.8 (77-167) minutes and an average blood loss of 486 mL (150-800 mL). All obtained resection margins were negative for cancer. Lymphovascular space invasion was noted in 11 (30.55 %) of the cases. No recurrences occurred during the study period. Seven (17.8 %) patients were able to become pregnant postoperatively, five of whom delivered healthy infants near term. Radical vaginal trachelectomy with laparoscopic pelvic lymphadenectomy appears to be a safe therapeutic option for fertility preservation in young women with early cervical cancer.
Collapse
|
14
|
Lloyd PA, Briggs EV, Kane N, Jeyarajah AR, Shepherd JH. Women's experiences after a radical vaginal trachelectomy for early stage cervical cancer. A descriptive phenomenological study. Eur J Oncol Nurs 2014; 18:362-71. [PMID: 24794078 DOI: 10.1016/j.ejon.2014.03.014] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2013] [Revised: 03/21/2014] [Accepted: 03/26/2014] [Indexed: 10/25/2022]
Abstract
PURPOSE This paper reports on a phenomenological study of women's experiences 1-10 years following a radical vaginal trachelectomy and describes the impact on health, sexuality, fertility and perceived supportive care needs. METHOD AND SAMPLE Qualitative telephone interviews employing a descriptive phenomenological approach were conducted using a purposive sample of 12 women. KEY RESULTS Several felt their cancer experience was positive; bringing them closer to family and changed their outlook on life. A few experienced delayed psychological reactions and/or fears of recurrence. Many experienced isolation and the desire to contact others with similar experiences. Women recovered well but a few experienced fears/concerns about lymphoedema and intermenstrual bleeding. Sexual function was not a long-term issue for most. Some that could feel the cerclage (stitch) during intercourse, developed techniques to reduce this. Single women felt vulnerable in new relationships. Pregnancy was an anxious time, especially for those that experienced a miscarriage or pre-term birth. Sources of support included the clinical nurse specialist, family/friends, surgical consultant, online patient forums and a support group. Women needed more information on trachelectomy statistics, pregnancy care recommendations as well as access to counselling, peer support, being seen by the same person and increased public awareness. CONCLUSIONS This study has provided an interesting and detailed insight into women's experiences in the years following a trachelectomy, with results that have important considerations for practice such as provision of statistical information; counselling; peer support; consistent pregnancy recommendations; increased public awareness and increased identification and management or prevention of long-term physical effects.
Collapse
Affiliation(s)
- Philippa A Lloyd
- Department of Gynaecological Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
| | - Emma V Briggs
- Florence Nightingale School of Nursing and Midwifery, Kings College London, UK.
| | - Nichola Kane
- Department of Gynaecological Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
| | - Arjun R Jeyarajah
- Department of Gynaecological Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
| | | |
Collapse
|
15
|
Ebisawa K, Takano M, Fukuda M, Fujiwara K, Hada T, Ota Y, Kurotsuchi S, Kanao H, Andou M. Obstetric outcomes of patients undergoing total laparoscopic radical trachelectomy for early stage cervical cancer. Gynecol Oncol 2013; 131:83-6. [PMID: 23917083 DOI: 10.1016/j.ygyno.2013.07.108] [Citation(s) in RCA: 52] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2013] [Revised: 07/25/2013] [Accepted: 07/26/2013] [Indexed: 11/25/2022]
Abstract
OBJECTIVE To assess the obstetric outcomes of our total laparoscopic radical trachelectomy (TLRT) cases for early stage cervical cancer. MATERIALS AND METHODS A total of 56 patients who underwent TLRT between December 2001 and August 2012 were reviewed retrospectively using clinicopathological, surgical, and follow-up data from patients' medical records. RESULTS We performed this operation on 56 patients during the study period. The mean age of these 56 patients was 31.9 years (range 22-42 years). Fifty-three patients' fertility was preserved without requiring post-operative adjuvant treatment. Twenty-five women attempted to conceive, of whom 13 succeeded for a total of 21 pregnancies (52% pregnancy rate). Ten of these 21 pregnancies were the result of assisted reproductive technologies. Of those, 5 resulted in first trimester miscarriages, 2 in second trimester miscarriages, and 13 in live births. Ten pregnancies reached the third trimester. Preterm premature rupture of membranes (8/13, 61.5%) was the most common complication during pregnancy. The rate of preterm delivery was 47.6%. Three patients delivered at 22-28 weeks of gestational age. Two of these babies showed permanent damage: one has cerebral palsy; the other has developmental retardation. One pregnancy is ongoing. CONCLUSION TLRT is a useful technique associated with an excellent pregnancy rate in fertility-preserving surgery to treat early stage cervical cancer.
Collapse
Affiliation(s)
- Keiko Ebisawa
- Department of Obstetrics and Gynecology, Kurashiki Medical Center, Japan.
| | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, Quinn G, Wallace WH, Oktay K. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013; 31:2500-10. [PMID: 23715580 PMCID: PMC5321083 DOI: 10.1200/jco.2013.49.2678] [Citation(s) in RCA: 1089] [Impact Index Per Article: 99.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022] Open
Abstract
PURPOSE To update guidance for health care providers about fertility preservation for adults and children with cancer. METHODS A systematic review of the literature published from March 2006 through January 2013 was completed using MEDLINE and the Cochrane Collaboration Library. An Update Panel reviewed the evidence and updated the recommendation language. RESULTS There were 222 new publications that met inclusion criteria. A majority were observational studies, cohort studies, and case series or reports, with few randomized clinical trials. After review of the new evidence, the Update Panel concluded that no major, substantive revisions to the 2006 American Society of Clinical Oncology recommendations were warranted, but clarifications were added. RECOMMENDATIONS As part of education and informed consent before cancer therapy, health care providers (including medical oncologists, radiation oncologists, gynecologic oncologists, urologists, hematologists, pediatric oncologists, and surgeons) should address the possibility of infertility with patients treated during their reproductive years (or with parents or guardians of children) and be prepared to discuss fertility preservation options and/or to refer all potential patients to appropriate reproductive specialists. Although patients may be focused initially on their cancer diagnosis, the Update Panel encourages providers to advise patients regarding potential threats to fertility as early as possible in the treatment process so as to allow for the widest array of options for fertility preservation. The discussion should be documented. Sperm and embryo cryopreservation as well as oocyte cryopreservation are considered standard practice and are widely available. Other fertility preservation methods should be considered investigational and should be performed by providers with the necessary expertise.
Collapse
Affiliation(s)
- Alison W. Loren
- Alison W. Loren, Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Anthony J. Magdalinski, Private Practice, Sellersville, PA; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Lindsay Nohr Beck, LIVESTRONG Foundation's Fertile Hope Program, Austin, TX; Kutluk Oktay, Innovation Institute for Fertility Preservation, New York Medical College, Rye and New York, NY; Lawrence Brennan, Oncology Hematology Care, Crestview Hills, KY; Ann H. Partridge, Dana-Farber Cancer Institute, Boston, MA; Gwendolyn Quinn, Moffitt Cancer Center, Tampa, FL; and W. Hamish Wallace, Royal Hospital for Sick Children, Edinburgh, United Kingdom
| | - Pamela B. Mangu
- Alison W. Loren, Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Anthony J. Magdalinski, Private Practice, Sellersville, PA; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Lindsay Nohr Beck, LIVESTRONG Foundation's Fertile Hope Program, Austin, TX; Kutluk Oktay, Innovation Institute for Fertility Preservation, New York Medical College, Rye and New York, NY; Lawrence Brennan, Oncology Hematology Care, Crestview Hills, KY; Ann H. Partridge, Dana-Farber Cancer Institute, Boston, MA; Gwendolyn Quinn, Moffitt Cancer Center, Tampa, FL; and W. Hamish Wallace, Royal Hospital for Sick Children, Edinburgh, United Kingdom
| | - Lindsay Nohr Beck
- Alison W. Loren, Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Anthony J. Magdalinski, Private Practice, Sellersville, PA; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Lindsay Nohr Beck, LIVESTRONG Foundation's Fertile Hope Program, Austin, TX; Kutluk Oktay, Innovation Institute for Fertility Preservation, New York Medical College, Rye and New York, NY; Lawrence Brennan, Oncology Hematology Care, Crestview Hills, KY; Ann H. Partridge, Dana-Farber Cancer Institute, Boston, MA; Gwendolyn Quinn, Moffitt Cancer Center, Tampa, FL; and W. Hamish Wallace, Royal Hospital for Sick Children, Edinburgh, United Kingdom
| | - Lawrence Brennan
- Alison W. Loren, Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Anthony J. Magdalinski, Private Practice, Sellersville, PA; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Lindsay Nohr Beck, LIVESTRONG Foundation's Fertile Hope Program, Austin, TX; Kutluk Oktay, Innovation Institute for Fertility Preservation, New York Medical College, Rye and New York, NY; Lawrence Brennan, Oncology Hematology Care, Crestview Hills, KY; Ann H. Partridge, Dana-Farber Cancer Institute, Boston, MA; Gwendolyn Quinn, Moffitt Cancer Center, Tampa, FL; and W. Hamish Wallace, Royal Hospital for Sick Children, Edinburgh, United Kingdom
| | - Anthony J. Magdalinski
- Alison W. Loren, Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Anthony J. Magdalinski, Private Practice, Sellersville, PA; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Lindsay Nohr Beck, LIVESTRONG Foundation's Fertile Hope Program, Austin, TX; Kutluk Oktay, Innovation Institute for Fertility Preservation, New York Medical College, Rye and New York, NY; Lawrence Brennan, Oncology Hematology Care, Crestview Hills, KY; Ann H. Partridge, Dana-Farber Cancer Institute, Boston, MA; Gwendolyn Quinn, Moffitt Cancer Center, Tampa, FL; and W. Hamish Wallace, Royal Hospital for Sick Children, Edinburgh, United Kingdom
| | - Ann H. Partridge
- Alison W. Loren, Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Anthony J. Magdalinski, Private Practice, Sellersville, PA; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Lindsay Nohr Beck, LIVESTRONG Foundation's Fertile Hope Program, Austin, TX; Kutluk Oktay, Innovation Institute for Fertility Preservation, New York Medical College, Rye and New York, NY; Lawrence Brennan, Oncology Hematology Care, Crestview Hills, KY; Ann H. Partridge, Dana-Farber Cancer Institute, Boston, MA; Gwendolyn Quinn, Moffitt Cancer Center, Tampa, FL; and W. Hamish Wallace, Royal Hospital for Sick Children, Edinburgh, United Kingdom
| | - Gwendolyn Quinn
- Alison W. Loren, Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Anthony J. Magdalinski, Private Practice, Sellersville, PA; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Lindsay Nohr Beck, LIVESTRONG Foundation's Fertile Hope Program, Austin, TX; Kutluk Oktay, Innovation Institute for Fertility Preservation, New York Medical College, Rye and New York, NY; Lawrence Brennan, Oncology Hematology Care, Crestview Hills, KY; Ann H. Partridge, Dana-Farber Cancer Institute, Boston, MA; Gwendolyn Quinn, Moffitt Cancer Center, Tampa, FL; and W. Hamish Wallace, Royal Hospital for Sick Children, Edinburgh, United Kingdom
| | - W. Hamish Wallace
- Alison W. Loren, Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Anthony J. Magdalinski, Private Practice, Sellersville, PA; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Lindsay Nohr Beck, LIVESTRONG Foundation's Fertile Hope Program, Austin, TX; Kutluk Oktay, Innovation Institute for Fertility Preservation, New York Medical College, Rye and New York, NY; Lawrence Brennan, Oncology Hematology Care, Crestview Hills, KY; Ann H. Partridge, Dana-Farber Cancer Institute, Boston, MA; Gwendolyn Quinn, Moffitt Cancer Center, Tampa, FL; and W. Hamish Wallace, Royal Hospital for Sick Children, Edinburgh, United Kingdom
| | - Kutluk Oktay
- Alison W. Loren, Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Anthony J. Magdalinski, Private Practice, Sellersville, PA; Pamela B. Mangu, American Society of Clinical Oncology, Alexandria, VA; Lindsay Nohr Beck, LIVESTRONG Foundation's Fertile Hope Program, Austin, TX; Kutluk Oktay, Innovation Institute for Fertility Preservation, New York Medical College, Rye and New York, NY; Lawrence Brennan, Oncology Hematology Care, Crestview Hills, KY; Ann H. Partridge, Dana-Farber Cancer Institute, Boston, MA; Gwendolyn Quinn, Moffitt Cancer Center, Tampa, FL; and W. Hamish Wallace, Royal Hospital for Sick Children, Edinburgh, United Kingdom
| |
Collapse
|
17
|
Speiser D, Köhler C, Schneider A, Mangler M. Radical vaginal trachelectomy: a fertility-preserving procedure in early cervical cancer in young women. DEUTSCHES ARZTEBLATT INTERNATIONAL 2013; 110:289-95. [PMID: 23671476 DOI: 10.3238/arztebl.2013.0289] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/04/2012] [Accepted: 01/23/2013] [Indexed: 11/27/2022]
Abstract
BACKGROUND Radical vaginal trachelectomy (RVT) is a fertility-preserving operation for young women who have cervical cancer in an early stage and want to have children. The demand for RVT is increasing, because more than 40% of all cases of cervical carcinoma affect women under the age of 44. Women are increasingly having their first child at later ages. METHODS We present the results of RVT in more than 300 patients whom we operated on, review pertinent literature retrieved by a selective PubMed search, and evaluate treatment recommendations. RESULTS The literature contains data on more than 1000 women treated with RVT and nearly 300 pregnancies after RVT. The 5-year recurrence and mortality rates are 2%-5% and 3%-6%, respectively. RVT is an oncologically safe treatment for women who want to have children. The main criteria for treatment with RVT are that the tumor should be no greater than 2 cm in diameter and that the lymph nodes should be histopathologically free of tumor tissue. The laparoscopic-vaginal technique is the best operative approach to assure a high rate of healing. Only one-third of all patients want to have children a short time after RVT. Their pregnancy rates resemble those of women in the general population. 50% of the children are born prematurely, mainly because of premature rupture of the membranes. Thus, pregnancies after RVT are considered high-risk pregnancies. CONCLUSION As many as 48% of women with early-stage cervical carcinoma meet the criteria for RVT. RVT is an oncologically safe method that enables women with early-stage cervical carcinoma to become pregnant and have children. Pregnancy after RVT is associated with an elevated risk of preterm birth and should be managed according to standardized procedures.
Collapse
Affiliation(s)
- Dorothee Speiser
- Department of Gynecology and Gynecological Oncology including Breast Center, Charité-Universitätsmedizin Berlin, Germany.
| | | | | | | |
Collapse
|
18
|
Difficulty in the management of pregnancy after vaginal radical trachelectomy. Int J Clin Oncol 2012; 18:1085-90. [DOI: 10.1007/s10147-012-0479-4] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2012] [Accepted: 09/05/2012] [Indexed: 10/27/2022]
|
19
|
Current World Literature. Curr Opin Obstet Gynecol 2012; 24:194-9. [DOI: 10.1097/gco.0b013e328353d51d] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|